SignatureFD’s Ocular Therapeutix OCUL Stock Holding History

SignatureFD’s Portfolio OCUL Stock Details OCUL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.89K	Buy	+341	New	+$3.25K	﹤0.01%	2951
2025 Q2	–	Sell	-781	Closed	-$5.72K	–	3377
2025 Q1	$5.72K	Buy	+781	New	+$6K	﹤0.01%	2552
2024 Q2	–	Sell	-76	Closed	-$692	–	3216
2024 Q1	$692	Buy	+76	New	+$539	﹤0.01%	2990
2023 Q2	–	Sell	-192	Closed	-$1.01K	–	3326
2023 Q1	$1.01K	Buy	+192	New	+$912	﹤0.01%	2991
2022 Q4	–	Sell	-1,195	Closed	-$5K	–	3376
2022 Q3	$5K	Buy	+1,195	New	+$6.02K	﹤0.01%	2447
2021 Q4	–	Sell	-134	Closed	-$1K	–	3218
2021 Q3	$1K	Hold	134	–	–	﹤0.01%	2875
2021 Q2	$2K	Hold	134	–	–	﹤0.01%	2605
2021 Q1	$2K	Hold	134	–	–	﹤0.01%	2508
2020 Q4	$3K	Hold	134	–	–	﹤0.01%	2159
2020 Q3	$1K	Buy	+134	New	+$1.11K	﹤0.01%	2467

Other funds holding OCUL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SignatureFD's OCUL Position: Q1 2026 in Review

SignatureFD opened a new position in Ocular Therapeutix (OCUL) in Q1 2026: 341 shares worth $2.89K. The stake represents ﹤0.01% of the portfolio and ranks #2951 among its holdings. This is a return to the name: SignatureFD previously reported a position in OCUL as recently as Q1 2025.

SignatureFD first reported a position in OCUL in Q3 2020 and has held it in 10 quarters since. The position peaked at $5.72K in Q1 2025. 269 funds tracked by Wall St. Rank hold OCUL as of Q1 2026.

SignatureFD held 341 shares of Ocular Therapeutix worth $2.89K as of Q1 2026.
Ocular Therapeutix was a new SignatureFD position in Q1 2026.
Ocular Therapeutix made up ﹤0.01% of SignatureFD's portfolio in Q1 2026, its #2951 holding.
SignatureFD first reported a position in Ocular Therapeutix in Q3 2020 and has held it in 10 quarters since.
SignatureFD's Ocular Therapeutix position peaked at $5.72K in Q1 2025.
269 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.